You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

CMEC Meeting 33, 15 March 2002

Complementary Medicines Evaluation Committee

15 March 2002

Extracted ratified minutes

How to access a pdf document

CMEC Meeting 33 extracted ratified minutes (pdf,51kb)

Public recommendation summary

This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.

Item 2 Minutes of CMEC's 32nd Meeting

Recommendation 33.1

CMEC confirms that the draft Minutes of its previous meeting (CMEC 32, 1 February 2002), as amended, are a true and accurate record of that previous meeting.

Item 6.1 Lutein

Recommendation 33.2

CMEC recommends to the TGA that lutein is suitable for use as an active ingredient in listable therapeutic goods, provided that it is stabilised to minimise degradation.

Item 8.1 Registration applications

One recommendation was made under this item.

Item 10.5 Review of evidence to support indications on the ARTG for a complementary medicine

One recommendation was made under this item.

Item 10.6 Review of evidence to support indications on the ARTG for a complementary medicine

One recommendation was made under this item.

Top of page